PE

Paul Eisenberg

Venture Partner at Apple Tree Partners

Malibu, California

Overview 

Paul Eisenberg is currently a Venture Partner at Apple Tree Partners in Malibu, California. With a background in biotechnology and pharmaceuticals, he has held senior roles at companies like Amgen and Eli Lilly, specializing in clinical development, regulatory submissions, and drug discovery. Eisenberg's career highlights include serving as Senior Vice President at Amgen in global medical and regulatory roles and making investments in companies such as Deep Apple Therapeutics during Series A funding.

Work Experience 

  • Venture Partner

    2019 - Current

Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Raised $5,000,000.00.

  • SVP Global Medical

    2017 - 2019

  • SVP Global Medical and CMO

    2014 - 2017

  • SVP-Regulatory and Safety

    2008 - 2014

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

Raised $28,500,000,000.00 from Citibank and Bank of America.

  • VP- Global Regulatory and Safety

    2006 - 2008

  • VP of Safety

    2005 - 2006

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

Raised $28,500,000,000.00 from Citibank and Bank of America.

  • VP of Global Patient Safety

    2002 - 2005

  • VP of General Medicine

    2000 - 2002

Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.

Raised $6,500,000.00.

  • ED Cardiovascular Therapeutic Area and Discovery

    1998 - 2000

Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.

Raised $6,500,000.00.

  • Professor of Medicine

    1983 - 1998

    Cardiovascular and Pulmonary Divisions

Articles About Paul

Relevant Websites